Email updates

Keep up to date with the latest news and content from Trials and BioMed Central.

Open Access Commentary

OMERACT: An international initiative to improve outcome measurement in rheumatology

Peter Tugwell1*, Maarten Boers2, Peter Brooks3, Lee Simon4, Vibeke Strand5 and Leanne Idzerda6

Author Affiliations

1 Department of Medicine, University of Ottawa and Institute of Population Health, Ottawa, Ontario, Canada

2 Department of Clinical Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands

3 Faculty of Health Sciences, The University of Queensland, Brisbane, Queensland, Australia

4 Harvard Medical School and Beth Israel Deaconess Medical Centre, Boston, MA, USA

5 Division of Immunology, Stanford University, CA, USA

6 Institute of Population Health, University of Ottawa, Ottawa, Ontario, Canada

For all author emails, please log on.

Trials 2007, 8:38  doi:10.1186/1745-6215-8-38

Published: 26 November 2007

Abstract

OMERACT is the acronym for an international, informally organized network initiated in 1992 aimed at improving outcome measurement in rheumatology. Chaired by an executive committee, it organizes consensus conferences in a 2-yearly cycle that circles the globe. Data driven recommendations are prepared and updated by expert working groups. Recommendations include core sets of measures for most of the major rheumatologic conditions. Since 2002 patients have been actively engaged in the process.